Back

Controversies in heart failure - Introduction to the session

27 August 2016 (11:00 - 11:15)
Organised by:
Congress Presentation Part of: Controversies in heart failure Pathophysiology and diagnosis ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Clyde Yancy

Northwestern University, Chicago (United States of America)

5 More presentations in this session

Presentation thumbnail
ACE - inhibitors should be replaced by LCZ696 as first line therapy for heart failure - PRO
Professor J. McMurray (Glasgow, GB)
Presentation thumbnail
ACE - inhibitors should be replaced by LCZ696 as first line therapy for heart failure - CON
Professor G. Rosano (London, GB)
Slides Video
Presentation thumbnail
B-Blockers and digoxin should be forgotten in atrial fibrillation heart failure - PRO
Professor S. Hohnloser (Frankfurt, DE)
Slides Video
Presentation thumbnail
B-Blockers and digoxin should be forgotten in atrial fibrillation heart failure - CON
Professor J. Bauersachs (Hannover, DE)
Slides Video
Presentation thumbnail
Controversies in heart failure - Conclusion
Professor S. Anker (Berlin, DE)
Video

Access the full session

Session thumbnail
Controversies in heart failure

The Event

Event poster

ESC Congress 2016

27 August 2016 11:00 CET
You may be interested in
thumbnail
Congress Session
Case-based discussion: device therapy in heart failure
17 May 2025
thumbnail
Congress Presentation
Expert panel
20 March 2026
thumbnail
Congress Session
Is decongestion the goal during acute heart failure treatment?
17 May 2025
thumbnail
Congress Session
Solving the puzzle of heart failure treatment
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources